Metoprolol and lisinopril together
Pro Research Analysisby 
Searched over 200M research papers
Combined Use of Metoprolol and Lisinopril in Treating Chronic Congestive Heart Failure and Hypertension
Introduction to Metoprolol and Lisinopril Combination Therapy
The combination of metoprolol, a beta-blocker, and lisinopril, an angiotensin-converting enzyme (ACE) inhibitor, is frequently used in the management of chronic congestive heart failure (CHF) and hypertension. This article synthesizes findings from multiple studies to evaluate the efficacy, safety, and benefits of using these medications together.
Efficacy in Chronic Congestive Heart Failure
Improved Cardiac Function
Studies have shown that the combination of metoprolol and lisinopril significantly improves cardiac function in patients with chronic congestive heart failure. One study involving 108 patients demonstrated that this combination therapy led to a significant decrease in left ventricular end-diastolic diameter (LVEDD) and increases in left ventricular ejection fraction (LVEF) and cardiac output (CO) compared to monotherapy with either drug alone . Another study with 96 patients found similar improvements in cardiac function, including reductions in heart rate, systolic blood pressure (SBP), and diastolic blood pressure (DBP) .
Enhanced Quality of Life
Patients treated with the combination of metoprolol and lisinopril reported better quality of life and fewer adverse events compared to those on monotherapy. This was highlighted in a study where patients experienced significant improvements in emotional, cognitive, and social functioning .
Efficacy in Hypertension Management
Blood Pressure Reduction
The combination therapy is also effective in managing hypertension. A study comparing the antihypertensive efficacy of lisinopril and metoprolol found that both drugs significantly reduced diastolic and systolic blood pressure. However, lisinopril showed a slightly greater reduction in systolic blood pressure . Another study confirmed that lisinopril improved arterial distensibility more effectively than metoprolol, which could contribute to better long-term cardiovascular outcomes .
Long-Term Benefits
In elderly patients with essential hypertension, lisinopril was found to be as effective as metoprolol in reducing both systolic and diastolic blood pressure. The study also noted that lisinopril was well-tolerated and did not cause serious adverse effects .
Safety and Side Effects
Tolerability
The combination of metoprolol and lisinopril is generally well-tolerated. In a study involving 360 patients, fewer adverse events were reported with lisinopril compared to metoprolol, and the frequency of withdrawals due to adverse events was lower with lisinopril . However, there are rare cases where lisinopril can cause the syndrome of inappropriate antidiuretic hormone secretion (SIADH), leading to hyponatremia .
Side Effects
Common side effects of metoprolol include fatigue, somnolence, and weight gain, while lisinopril can cause headaches, dizziness, and rash. Despite these side effects, the combination therapy is considered safe for most patients when monitored appropriately 36.
Conclusion
The combination of metoprolol and lisinopril offers significant benefits in the treatment of chronic congestive heart failure and hypertension. It improves cardiac function, reduces blood pressure effectively, and enhances the quality of life for patients. While generally well-tolerated, it is essential to monitor for potential side effects, including rare but serious conditions like SIADH. Overall, this combination therapy is a valuable option in clinical practice for managing these conditions.
Sources and full results
Most relevant research papers on this topic
Curative effect of metoprolol succinate sustdined-release tablet combined with lisinopril in the treatment of chronic congestive heart failure
Metoprolol succinate sustdined-release tablet combined with lisinopril significantly improves cardiac function and is worthy of clinical application in chronic congestive heart failure patients.
A Clinical Study of Using Accompanied Lisinopril with Metoprolol in the Patients with Congestive Heart Failure
Lisinopril accompanied with metoprolol effectively improves cardiac function and has few side effects in patients with congestive heart failure.
Evaluation of Antihypertensive Efficacy of Lisinopril Compared to Metoprolol in Moderate to Severe Hypertension
Lisinopril 40-80 mg once daily is as effective as metoprolol 100-200 mg once daily in reducing diastolic blood pressure in patients with moderate to severe hypertension, with greater reduction in systolic and mean arterial pressures.
[Antihypertensive efficacy of a low-dose combination of amlodipine and lisinopril in the treatment of arterial hypertension in postmenopausal women].
A low-dose combination of amlodipine (5 mg) and lisinopril (equator) effectively reduces blood pressure and improves diastolic left ventricular function in postmenopausal women with arterial hypertension.
Quality of life, side effects and efficacy of lisinopril compared with metoprolol in patients with mild to moderate essential hypertension.
Both lisinopril and metoprolol effectively reduce blood pressure in mild to moderate essential hypertension, with lisinopril being better tolerated and showing better quality of life improvements.
Valsartan versus lisinopril or extended-release metoprolol in preventing cardiovascular and renal events in patients with hypertension.
Valsartan may reduce the risk of major cardiovascular and renal events compared to extended-release metoprolol in patients with hypertension.
DOI